PCA Total Hip System (Cementless Use)
by Pfizer Hospital Products Group, Inc. 510(k)
Active
510(k) K920831
Overview
The PCA Total Hip System (Cementless Use) is an orthopedic device intended for total hip arthroplasty without the use of bone cement. It is designed for implantation in patients requiring hip joint replacement where bony ingrowth is expected to provide long-term fixation.
This device is supplied non-sterile and requires sterilization prior to use. It is intended for use in a hospital operating room setting by qualified orthopedic surgeons. The system includes femoral and acetabular components as specified in the 510(k) clearance K920831 under product code LPH, and is regulated as a Class II medical device by the FDA.
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK920831 | Date10 Jun 1992 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not known
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- LPH
- Device Class
- Class II
- Regulation
- 21 CFR Part 888.3358
- Advisory Committee
- Orthopedic
- FDA Decision
- SESE Substantially Equivalent
Other devices from Pfizer Hospital Products Group, Inc.
Questions
What is the PCA Total Hip System (Cementless Use) intended for?
The PCA Total Hip System (Cementless Use) is intended for total hip arthroplasty without bone cement, designed for implantation in patients requiring hip joint replacement where bony ingrowth is expected to provide long-term fixation.
How is the PCA Total Hip System supplied and prepared for use?
The device is supplied non-sterile and requires sterilization prior to use by qualified orthopedic surgeons in a hospital operating room setting.
What components are included in the PCA Total Hip System?
The system includes femoral and acetabular components as specified in the 510(k) clearance K920831 under product code LPH.